Literature DB >> 31111627

Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions.

Adrian G McNicholl1, Javier Amador2, Mercedes Ricote3, Pedro J Cañones-Garzón4, Emili Gene5, Xavier Calvet6, Javier P Gisbert1.   

Abstract

INTRODUCTION: Dyspepsia and Helicobacter pylori are two of the most relevant digestive conditions in primary care. Several consensuses on the subject have been published, but the assimilation/implementation of these guidelines is uncertain. AIMS AND METHODS: To evaluate the attitudes, perceptions, limitations, and adherence to recommendations of Spanish primary care physicians using an open online survey. Responses were anonymously codified. Estimated margin of error was 3.4%. Responses were weighted by province, gender, age, and type of practice. Survey was performed using the AEG-REDCap platform.
RESULTS: A total of 1445 responses, received between December 2017 and April 2018, were analyzed. Women represented 54%, and the average age was 48 years; 59% were from urban context, 20% from semi-urban, and 21% from rural; 93% provided public practice. Over 40% had read at least one Maastricht consensus (24% Maastricht V), and 34% had attended a course related to H. pylori. 16% reported no direct access to any validated diagnostic method, only 44% to urea breath test, and 33% did not systematically refer to eradication confirmation test. The first-line treatment of choice was standard triple therapy in 56%, followed by concomitant therapy (28%). Only 20% of physicians had optimal adherence to recommendations.
CONCLUSION: Even though some improvements from guidelines have been partially incorporated, the level of penetration of recommendations is still poor and delayed. To provide optimal primary care, the barriers for implementation, access to diagnostic tests and to continuous medical education, should be removed. Rigorous dissemination, implementation, and evaluation programs are desired in future consensuses.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Helicobacter pylorizzm321990; attitudes; dyspepsia; general practitioner; primary care; survey

Mesh:

Year:  2019        PMID: 31111627     DOI: 10.1111/hel.12593

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  4 in total

1.  Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD.

Authors:  Rocco Maurizio Zagari; Marco Romano; Leonardo Frazzoni; Giovanni Marasco; Elton Dajti; Paolo Giorgio Arcidiacono; Alessandro Armuzzi; Federico Biagi; Renato Cannizzaro; Giulia Martina Cavestro; Carolina Ciacci; Fabio Monica; Sergio Peralta; Franco Radaelli; Franco Bazzoli
Journal:  Helicobacter       Date:  2021-11-11       Impact factor: 5.182

2.  Helicobacter pylori infection and lactose intolerance increase expiratory hydrogen.

Authors:  Wolfgang J Schnedl; Nathalie Meier-Allard; Michael Schenk; Sonja Lackner; Dietmar Enko; Harald Mangge; Sandra J Holasek
Journal:  EXCLI J       Date:  2022-02-17       Impact factor: 4.068

3.  Evaluation of a New Monoclonal Chemiluminescent Immunoassay Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: A Spanish Multicentre Study.

Authors:  Elena Resina; María G Donday; Samuel J Martínez-Domínguez; Emilio José Laserna-Mendieta; Ángel Lanas; Alfredo J Lucendo; Marta Sánchez-Luengo; Noelia Alcaide; Luis Fernández-Salazar; Luisa De La Peña-Negro; Luis Bujanda; Marta Gómez-Ruiz de Arbulo; Javier Alcedo; Ángeles Pérez-Aísa; Raúl Rodríguez; Sandra Hermida; Yanire Brenes; Olga P Nyssen; Javier P Gisbert
Journal:  J Clin Med       Date:  2022-08-29       Impact factor: 4.964

4.  High Effectiveness of a 14-Day Concomitant Therapy for Helicobacter pylori Treatment in Primary Care. An Observational Multicenter Study.

Authors:  Llum Olmedo; Rafael Azagra; Amada Aguyé; Marta Pascual; Xavier Calvet; Emili Gené
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.